首页> 外国专利> Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents

Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents

机译:使用药物洗脱支架治疗脆弱冠状动脉斑块的方法和装置

摘要

A drug-eluting intravascular stent comprising an anti-restenosis agent covered by a biodegradable coating, and a method for treating vulnerable plaque in coronary vessels using said stent is disclosed. The biodegradable layer covers at least a portion of the drug-eluting layer of the stent, and is adapted to slowly erode over a preset period of time, preventing the release of therapeutic amounts of the anti-restenosis agent from the drug-eluting layer during the preset period. By delaying the release of the anti-restenosis agent, a thin layer of neointima will grow during the preset period. This tissue growth is sufficient to encapsulate the stent and cover the vulnerable plaque, but not significant enough to cause harmful restenosis or occlusion of the vessel. Once the biodegradable coating is eroded, the anti-restenosis agent begins release from the drug-eluting layer, and the progression of neointimal hyperplasia ceases.
机译:公开了一种药物洗脱的血管内支架,其包括被可生物降解涂层覆盖的抗再狭窄剂,以及使用所述支架治疗冠状血管中易损斑块的方法。可生物降解层覆盖支架的药物洗脱层的至少一部分,并且适于在预定的时间段内缓慢侵蚀,从而防止在治疗期间从药物洗脱层释放治疗量的抗再狭窄剂。预设时间段。通过延迟抗再狭窄剂的释放,新内膜薄层将在预设时间内生长。这种组织生长足以包封支架并覆盖易损斑块,但不足以引起有害的血管再狭窄或阻塞。一旦可生物降解的涂层被侵蚀,抗再狭窄剂就开始从药物洗脱层释放,新内膜增生的进程就停止了。

著录项

  • 公开/公告号US2004002755A1

    专利类型

  • 公开/公告日2004-01-01

    原文格式PDF

  • 申请/专利权人 FISCHELL DAVID R.;SPALTRO JOHN;

    申请/专利号US20020185021

  • 发明设计人 JOHN SPALTRO;DAVID R. FISCHELL;

    申请日2002-06-28

  • 分类号A61F2/06;

  • 国家 US

  • 入库时间 2022-08-21 23:14:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号